Recruiting Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer NCT06736379 Conditions Carcinoma, Carcinoma, Squamous Cell, HNSCC, +22 more Locations Stanford University — Stanford, California, United States View Trial Details
Completed Study of XB002 in Subjects With Solid Tumors (JEWEL-101) NCT04925284 Conditions Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more Locations Exelixis Clinical Site #48 — Birmingham, Alabama, United States Exelixis Clinical Site #20 — Tucson, Arizona, United States Exelixis Clinical Site#95 — Tucson, Arizona, United States Exelixis Clinical Site#58 — Little Rock, Arkansas, United States View all 95 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma NCT04107103 Conditions SCCHN Locations Cross Cancer Institute — Edmonton, Alberta, Canada View Trial Details
Completed A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors NCT02573259 Conditions Carcinoma, Carcinoma, Transitional Cell, Melanoma, +21 more Locations Clinical Research Unit — Los Angeles, California, United States Ronald Reagan Medical Center, Department of Radiological Sciences — Los Angeles, California, United States Ronald Reagan UCLA Medical Center, Drug Information Center — Los Angeles, California, United States UCLA Hematology & Oncology Clinic — Los Angeles, California, United States View all 67 locations View more locations Show fewer locations Loading locations... View Trial Details
